Latest Synlait News

Synlait Milk Limited has completed the sale of its North Island assets to Abbott for NZ$307 million, significantly reducing its bank debt and refocusing its operations on Canterbury.

Synlait confirms the imminent sale of its North Island assets to Abbott for NZ$307 million, aiming to reset its balance sheet amid a challenging half-year result. The company unveils a recovery roadmap focused on stabilising and scaling its core operations.

Synlait Milk Limited has reported a significant half-year loss driven by manufacturing setbacks and market pressures, alongside a strategic recovery roadmap focused on asset sales and operational overhaul.

Synlait Milk Limited has secured important amendments and waivers to its syndicated bank facilities, aligning its financial covenants with the upcoming sale of its North Island assets scheduled for April 2026.

Synlait Milk Limited reveals a challenging first half of 2026 with significant losses expected, as it pivots its operations around Canterbury following the upcoming sale of its North Island assets.

Synlait Milk Limited has temporarily expanded its banking facilities by NZ$50 million to manage ongoing cost impacts from earlier manufacturing challenges, while preparing to reduce debt through a major asset sale.

Abbott has received Overseas Investment Office approval to acquire Synlait Milk’s North Island manufacturing and warehouse facilities in a US$178 million deal, pending shareholder consent.

Synlait Milk Limited reports a modest profit turnaround in FY25 and announces a major sale of its North Island assets to Abbott, aiming to reduce debt and sharpen its focus on core operations.

Synlait has agreed to sell its North Island assets to global healthcare giant Abbott for approximately US$178 million, marking a strategic reset focused on debt reduction and operational simplification. The deal, expected to close by April 2026, positions Synlait to concentrate on its South Island operations and explore new growth avenues.

Synlait Milk Limited reported an 11.7% rise in revenue to NZD 1.83 billion for the year ending July 2025, yet its net loss deepened sharply to nearly NZD 40 million, prompting a halt on dividends.

Synlait Milk Limited has completed a $350 million refinancing package with a strong banking syndicate, featuring amended financial covenants for FY26 and maintaining key shareholder support.

Synlait Milk Limited reports a significant financial turnaround for FY25 with expected underlying EBITDA doubling from the prior year, while overcoming manufacturing setbacks at its Dunsandel facility.